Tsun Hon, Peter Wong

Wong Tsun Hon, Peter

  • Professor, Department of Pharmacology
Academic Qualifications
  • PhD, University of London King's College, United Kingdom
  • BSc, University of London King's College, United Kingdom
Research Interest(s)
  • Cerebral Ischaemia
  • Stroke
  • Neural Degeneration
  • Regeneration
  • Hydrogen Sulfide
  • Behavioural Neuroscience
Recent Publications
  • 1. Liu FJ, Kaur P, Karolina DS, Sepramaniam S, Armugam A, Wong PT, Jeyaseelan K. 2015 Jun. MiR-335 Regulates Hif-1α to Reduce Cell Death in Both Mouse Cell Line and Rat Ischemic Models. PLoS One. 10(6):e0128432. doi: 10.1371/journal.pone.0128432. 26030758.
  • 2. Chan SJ, Chai C, Lim TW, Yamamoto M, Lo EH, Lai MK, Wong PT. 2015 Apr. Cystathionine ß-synthase inhibition is a potential therapeutic approach to treatment of ischemic injury. ASN Neuro. 7(2). doi: 10.1177/1759091415578711. 25873304.
  • 3. Li K, Yamamoto M, Chan SJ, Chiam MY, Qin W, Wong PT, Yim EK, Tang BZ, Liu B. 2014 Dec. Organic nanoparticles with aggregation-induced mmission for tracking bone marrow stromal cells in the rat ischemic stroke model. Chem Commun (Camb). 50(96):15136-9. doi: 10.1039/c4cc06921h. 25267167.
  • 4. Wong SY, Chan SJ, Wong WS, Wong PT, Lai MK. 2014 Aug. Andrographolide attenuates interleukin-1ß-stimulated upregulation of chemokine CCL5 and glial fibrillary acidic protein in astrocytes. Neuroreport. 25(12):881-6. doi: 10.1097/WNR.0000000000000179. 24949817.
  • 5. Tan MG, Lee C, Lee JH, Francis PT, Williams RJ, Ramírez MJ, Chen CP, Wong PT, Lai MK. 2014 Jan. Decreased rabphilin 3A immunoreactivity in Alzheimer’s disease is associated with Aβ burden. Neurochem Int. 64:29-36. doi: 10.1016/j.neuint.2013.10.013. 24200817.